Hem › Esophageal adenocarcinom › North Carolina
Kliniska studier för Esophageal adenocarcinom i North Carolina
12 studier för Esophageal adenocarcinom söker deltagare vid platser i North Carolina.
Städer i North Carolina
Officiell studietext (engelska)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- Southeastern Medical Oncology Center-Clinton, Clinton
- och 6 fler
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- och 5 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- University of North Carolina Medical Center, Chapel Hill
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07221149Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
- Duke University Medical Center, Durham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07603375Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- University of North Carolina at Chapel Hill, Chapel Hill
RekryterarFriska volontärer välkomna
Ålder 50 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06687603Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- University of North Carolina School of Medicine, Chapel Hill
Rekryterar
Ålder 18 till 89 · Alla kön · Uppdaterad 11 sep. 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Charlotte
- Research Site, Wilmington
- Research Site, Winston-Salem
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07431281Obeticholic Acid for Prevention in Barrett's Esophagus
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT04939051Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- University of North Carolina at Chapel Hill, Chapel Hill
Rekryterar
Ålder 18 till 89 · Alla kön · Uppdaterad 1 juli 2026 · NCT05530343First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 12 juni 2026 · NCT07284186A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- Durham VA Medical Center, Durham, NC, Durham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 nov. 2025 · NCT05563766Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.